Administration of Moderate Sedation & Analgesia Course

Administration of Moderate Procedural Sedation and Analgesia: Keeping the Patient Safe, 8th Ed.

A comprehensive review of current evidence-based guidelines for IDENTIFYING RISKS AND managing patients who receive moderate PROCEDURAL sedation and analgesia.

NEW EDITION ...

Sedation and analgesia are frequently administered to patients in both hospital and ambulatory settings to relieve the pain, discomfort and anxiety associated with diagnostic or therapeutic procedures. Sedation and analgesia are often necessary to minimize patient movement so that procedures can be performed safely and successfully in the most expedient fashion. Staff that are involved in the care of patients who require sedation and analgesia should be knowledgeable of the essential components of the process so that the patient's experience is optimized while risks to patient safety are minimized. Patients must be fully assessed and monitored, and optimal dosages of sedative and analgesic agents must be carefully determined based upon patient characteristics and procedure requirements to avoid the deleterious consequences of cardiac or respiratory depression (i.e. hypoxic brain damage, cardiac arrest, or death).

This educational activity will provide reinforcement of evidence-based standards for administering moderate sedation and analgesia in both hospital and ambulatory settings; and will provide a review of current guidelines for safely managing and monitoring sedated patients in such settings.

The course material is presented in five segments:

The physiological effects of moderate procedural sedation and analgesia.
Pre-procedure patient assessment and preparation.
Peri-procedure monitoring and management of patients receiving moderate procedural sedation and analgesia.
Pharmacology of analgesics, sedatives and antagonists used for moderate sedation of adult and pediatric patients.
Post-procedure management and discharge of patients who received moderate sedation and analgesia.

Instructions for completing this course

Target Audience

Registered Nurses and licensed health professionals in patient care settings where patients receive moderate procedural sedation and analgesia.

Contact Hours

2.5 Contact Hours will be awarded upon successful completion of this activity.

The contact hours for this activity expire: 10/20/2028

This nursing continuing professional development activity was approved by the American Association of Critical-Care Nurses, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Approval refers to recognition of continuing education only and does not imply AACN or ANCC approval or endorsement of the content of this educational activity.

Learning Outcome / Goal Of This Activity:

Upon completion of this activity, RNs and licensed health professionals will gain new knowledge and a greater understanding of the evidence-based standards that are known to keep a patient safe during all phases of the moderate sedation and analgesia process.

Objectives

Upon completion of this activity, the participant will be able to:

Describe the four levels in the continuum of sedation.
Explain the goals of moderate procedural sedation and analgesia.
Identify essential components of the pre-procedure patient assessment.
Summarize current recommendations for pre-procedure fasting.
Describe methods for assessing a patient’s level of consciousness during procedural sedation.
Describe methods for monitoring oxygenation, ventilation, cardiovascular function, and other physiologic parameters during procedural sedation.
Identify appropriate interventions for airway obstruction, hypoventilation, apnea, and progression to a deeper-than-intended level of sedation.
Identify monitoring, airway, ventilation, and resuscitation equipment that should be immediately available during moderate procedural sedation.
Identify important adverse effects and safety considerations associated with commonly used analgesics and sedatives.
Explain factors that influence the selection and titration of medications used for procedural sedation and analgesia.
Identify appropriate indications and precautions for the use of opioid and benzodiazepine antagonists.
Describe criteria used to assess recovery and determine readiness for discharge following moderate procedural sedation.

Requirements For Successful Completion of this Program

Using this Self-Directed Learning Module, you must review the objectives and read the materials. As you read through the material on the course pages, you will be occasionally prompted to answer knowledge assessment questions. There is a total of 35 multiple choice questions in this course. You must achieve a grade of 80% (28 correct answers) to receive a certificate.

When you have answered the last question, the Course Results page will display. This page will contain your final grade and allow you to immediately print your certificate if you have scored a minimum grade of 80%. Your certificate will also be available on your Control Panel where you may print it at any time.

Course work does not need to be completed in one online session. You can log off at any point and return to the course at your convenience.

The Course Reference Page available at the completion of the course will contain many useful reference documents from notable sources pertinent to material covered in this course.

Disclosures from Authors and Program Planners

Regina Napolitano, RN, MA, served as the author and program planner of this activity and discloses no relevant financial relationship with ineligible companies.

Claude V. Baconcini, CRNA, served as a program planner and content expert and discloses no relevant financial relationship with ineligible companies.

Registration Fee

The registration fee for this course is $35.00. Your registration fee includes two opportunities to pass the examination and permanent access to all reference material.

If you have any questions or concerns about this course, you may contact a Customer Service representative at 888-345-6788, or e-mail us at ceo.contact7@proceo.com.